|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
J Biol Chem, Vol. 273, Issue 35, 22729-22737, August 28, 1998
From the Activation of protein kinases plays an important
role in the Ca2+-dependent stimulation of
insulin secretion by nutrients. The aim of the present study was to
identify kinase substrates with the potential to regulate secretion
because these have been poorly defined. Nutrient stimulation of the rat
insulinoma RINm5F cell line and rat pancreatic islets resulted in an
increase in the threonine phosphorylation of a 200-kDa protein. This
was secondary to the gating of voltage-dependent
Ca2+ channels because it was reproduced by depolarizing KCl
concentrations and blocked by the Ca2+ channel antagonist,
verapamil. The peak rises in [Ca2+]i preceded or
were coincident with the maximal threonine phosphorylation in response
to both glyceraldehyde and KCl. In digitonin-permeabilized RINm5F cells
a rise in Ca2+ from 0.1 to 0.15 µM was
sufficient to increase phosphorylation. Protein kinase C, protein
kinase A, and Ca2+/calmodulin-dependent kinase
II did not appear to be responsible for the phosphorylation, yet the
Ca2+ dependence of the response suggests possible
involvement of other members of the
Ca2+/calmodulin-dependent kinase family. The
200-kDa protein was identified as myosin heavy chain by
immunoprecipitation with a polyclonal nonmuscle myosin antibody.
Phosphopeptide mapping indicated that the site of phosphorylation on
myosin heavy chain was the same for both KCl- and
glyceraldehyde-stimulated cells. Phosphoamino acid analysis confirmed a
low basal phosphothreonine content of myosin heavy chain, which
increased 6-fold in response to KCl. A lesser (2-fold) increase in
serine phosphorylation was also detected using this technique. Although
myosin IIA and IIB were shown to be present in RINm5F cells and rat
islets, myosin IIA was the predominant threonine-phosphorylated
species, suggesting that the two myosin species might be independently
regulated. Our results identify myosin heavy chain as a novel kinase
substrate in pancreatic Glucose is a major metabolic regulator of insulin secretion from
the Although these initial consequences of glucose metabolism within the
Cytoskeletal proteins have long been suspected to play a role in
insulin secretion (17). Myosin is one of the major cytoskeletal proteins in eukaryotic cells (18). It functions primarily as a motor
protein and is therefore involved in a diverse range of cellular
functions including cytokinesis and cellular movement and has also been
postulated to be involved in secretion (19-22). Conventional, Type II
myosin forms part of the diverse family of vertebrate myosin proteins.
It is a hexameric complex of proteins that consists of two 200-kDa
heavy chains noncovalently bound to two pairs of light chains (17-22
kDa), of which one pair is classified as essential and the other pair
is classified as regulatory (20). Cloning of the Type II myosin heavy
chain (MHC) has shown that there are three general classes: smooth
muscle, cardiac muscle, and nonmuscle myosin (23). Isoforms of MHC also
exist within these groups. Conventional smooth muscle myosin has two
alternatively spliced isoforms, MHC 200 and MHC 204 (24, 25), whereas
nonmuscle MHC is comprised of two genetically distinct isoforms
referred to as MHC-A and MHC-B (26, 27).
Regulation of the myosin-actin complex is thought to occur
predominantly via the phosphorylation of the regulatory light chains at
a number of specific sites. It has been shown that MLC kinase phosphorylates MLC sequentially on serine 19 and threonine 18 (28). In
mast cells, PKC phosphorylates MLC on serine 1 and serine 2 residues
(21). Phosphorylation of MLC by MLC kinase is thought to help stabilize
the three-dimensional structure of the myosin complex and increase the
actin-activated ATPase activity (29), whereas phosphorylation of MLC
with PKC appears to have no obvious effect on myosin contractile
activity. Although a number of recent studies have shown that MHC can
also undergo phosphorylation in protozoans (30, 31, 60), there are few
reports of phosphorylation of this protein in vertebrates.
The aim of this study was to define changes in
Ca2+-dependent protein phosphorylation upon
nutrient stimulation of rat pancreatic islets and RINm5F cells. The
latter are rat insulinoma cells that secrete insulin in response to
glyceraldehyde via mechanisms similar to those initiated by glucose in
native Materials--
Reagents were of analytical grade and were
obtained from Sigma, Calbiochem (Alexandria, NSW, Australia), BDH
(MERCK Pty Limited, VIC, Australia), or Bio-Rad unless otherwise
stated. Tissue culture supplies were obtained from Life Technologies,
Inc. except the fetal and newborn calf serum, which was purchased from
CSL Limited (Parkville, VIC, Australia). Anti-myosin (nonmuscle)
antibody was from Biomedical Technologies Inc. (Stoughton, MA).
Anti-phosphothreonine and anti-phosphoserine antibodies were purchased
from Zymed Laboratories Inc. (San Francisco, CA). The
myosin IIA and myosin IIB antibodies were a generous gift from Dr.
Robert Adelstein (Laboratory of Molecular Cardiology, NIH, Bethesda,
MD). Donkey anti-rabbit horseradish peroxidase-conjugated secondary
antibody was obtained from Jacksons Immunoresearch Laboratory Inc.
(West Grove, PA). Insulin radioimmunoassay kit was purchased from Linco
Research Inc. (St. Charles, MO). Fura 2 (free acid) and Fura 2AM were
obtained from Molecular Probes (Eugene, OR). Enhanced chemiluminescence
reagents for immunoblotting were purchased from NEN Life Science
Products. [32P]Orthophosphoric acid was obtained from
Amersham Life Science (Buckinghamshire, UK).
Isolation and Incubation of Islets--
Islets were isolated
from 230-270-g male Wistar rats by ductal infusion of collagenase and
cultured as described previously (33). Batches of 200-300 islets were
picked and washed with a modified KRB containing 5 mM
NaHCO3, 1 mM CaCl2, 2.8 mM glucose, 10 mM Hepes (pH 7.4), and 0.5%
(w/v) BSA. The islets were preincubated in 0.2 ml BSA-free KRB for 10 min at 37 °C. Stimulating solutions (0.8 ml) were then added, and
the islets were incubated at 37 °C for the time periods as stated.
The incubation was terminated by gentle centrifugation and rapid
removal of the supernatant. Islets were resuspended in 50 µl of RIPA
buffer (1% (w/v) deoxycholate, 1% (v/v) Triton X-100, 0.1% (w/v)
SDS, 150 mM NaCl, 1 mM EDTA, 2 mM
sodium orthovanadate in 50 mM Tris-HCl (pH 7.4)). Extracts were then sonicated 3 × 10 s using a Branson model 250 sonifier and microtip at power setting 1 and 10% duty cycle.
Cell Culture--
RINm5F cells were maintained in T-75 tissue
culture flasks in RPMI 1640 supplemented with 2 mM
glutamine, 10% heat-inactivated fetal calf serum, 100 units/ml
penicillin and 100 µg/ml of streptomycin in 5% CO2:95%
air at 37 °C. For studies with cell suspensions, monolayers were
treated with trypsin/EDTA solution. Cells were then allowed to recover
in a spinner medium (containing the same components as the culturing
medium with the addition of 10 mM Hepes and 1% newborn
calf serum instead of 10% fetal calf serum) for 3 h at 37 °C.
RBL-2H3 and COS-7 cells were maintained and used as adherent monolayers
as described previously (34, 35).
Measuring Insulin Secretion--
Cells were harvested from the
spinner medium and resuspended in KRB with 0.1% (w/v) BSA at 1 × 106 cells/ml. 1-ml aliquots were placed into 1.5-ml
centrifuge tubes and preincubated at 37 °C. After 15 min, 800 µl
of supernatant was removed and pooled to enable measurement of
background secretion. Stimulating solutions (800 µl of 1.2×
concentrate) were added, and the cells were incubated at 37 °C for a
further 15 min. Incubations were terminated by placing the samples on
ice. Cells were then pelleted by centrifugation at 13,000 × g at 4 °C, and the resulting supernatant was removed to
determine insulin content using a radioimmunoassay kit with rat insulin
as standard.
Intracellular Ca2+ Measurements--
The
fluorescence dye Fura 2AM (1 µM) was added 30 min prior
to removing cells from the spinner medium. Cells were then washed three
times in spinner medium and resuspended at 5 × 106
cells/ml. Aliquots of 0.4 ml (2 × 106 cells) were
centrifuged (90 × g for 5 min), and the pellets were resuspended in 2 ml of KRB containing 0.1% (w/v) BSA and 200 µM sulfinpyrazone. Cells were activated by the addition
of glyceraldehyde (10 mM) or KCl (30 mM), and
the fluorescence was measured at 37 °C on a HITACHI F-4010
fluorescence spectrophotometer using an excitation wavelength of 340 nm
and an emission wavelength of 505 nm.
Permeabilization with Digitonin--
Cells were harvested from
spinner medium as described above and resuspended in a potassium
glutamate buffer (buffer A: 140 mM potassium glutamate, 5 mM NaCl, 2 mM MgSO4, and 20 mM Hepes (pH 7.0)) at a concentration of 5 × 106 cells/ml (36). Aliquots (2 ml) were preincubated at
37 °C for 10 min. Digitonin (final concentration, 10 µM) was added to the cells, and they were incubated for a
further 5 min. Permeabilization was terminated with the addition of 30 ml of ice-cold buffer A. Cells were then recovered after gentle
centrifugation at 60 × g for 10 min and resuspended at
1.5 × 107 cells/ml in buffer A with the addition of 5 mM Mg-ATP. Efficiency of cell permeabilization was measured
using Trypan blue and was routinely 60-70% permeabilized. A 200-µl
(3 × 106 cells) aliquot of cells was then incubated
on ice for 10 min with Ca2+/EGTA buffer. Defined free
Ca2+ concentrations over a range of 10 Immunoblot Analysis--
Cells were incubated and stimulated in
BSA-free KRB as for the insulin secretion studies. At the end of the
incubation period, 1 × 106 to 3 × 106 cells were centrifuged, supernatant was removed, and
cells were then lysed by the addition of 50 µl of RIPA buffer and
sonicated as described in the islet experiments. A 10-15-µl aliquot
of sample was then denatured in Laemmli sample buffer (37) for 5 min at 100 °C prior to SDS-PAGE. Proteins were transferred to
nitrocellulose membranes, and transfer efficiency was checked by
staining of the membrane with Ponceau Red. The membrane was then
blocked for 1 h in Tris-buffered saline containing 0.05% (v/v)
Tween 20 and 5% (w/v) nonfat milk powder. Incubation with the primary
antibodies was for 2 h at room temperature followed by a 1-h
incubation with horseradish peroxidase-conjugated secondary antibody.
Bands were visualized using immunoblot chemiluminescence reagents. In
the competition experiments the phosphothreonine antibody was
preincubated for 2 h at room temperature with differing
(phospho)amino acids (1 mM) and then used for
immunoblotting as described above. When required, membranes were
stripped of antibodies using a buffer containing 2% (w/v) SDS, 100 mM Immunoprecipitation from RINm5F Cells--
Cells were seeded
into a 6-well plate at 3 × 106 cells/well and
cultured overnight at 37 °C. Attached RINm5F cells were used in the
immunoprecipitation experiments because they showed a similar increase
in threonine phosphorylation of all proteins upon stimulation with KCl
(data not shown) but were easier to manipulate under these
circumstances than those in suspension. Cells were washed twice with 3 ml of KRB and preincubated in 2 ml of KRB at 37 °C for 10 min.
Medium (1.6 ml) was then removed, and cells were activated with the
addition of 1.6 ml of stimulating solutions. The incubation was
terminated by placing the cells on ice and removing the medium. Lysis
buffer (450 µl) containing 1% (v/v) Nonidet P-40, 100 mM sodium pyrophosphate, 250 mM NaCl, 50 mM NaF, 5 mM EGTA, 0.1 mM phenylmethylsulfonyl fluoride,
10 µg/ml leupeptin, 15 mM [32P]Orthophosphate Labeling of RINm5F
Cells--
Cells were cultured and seeded in 6-well plates as
described above. On the day of the experiment, medium was removed, and cells were gently washed twice with a phosphate-free salt solution (119 mM NaCl, 5 mM KCl, 5.6 mM glucose,
0.4 mM MgCl2, 1 mM
CaCl2, 0.1% (w/v) BSA, 4 mM glutamine, and 25 mM PIPES-NaOH (pH 7.2) (38). Cells were then labeled with
[32P]orthophosphoric acid (200 µCi/well) for 2 h
at 37 °C. Radioactive supernatant was removed, and cells were washed
once with 3 ml of warmed phosphate-free buffer and once with 3 ml of
KRB. Cells were preincubated in 2.5 ml of KRB for 10 min at 37 °C.
Cells were then stimulated for 5 min, and the incubation was stopped by
aspirating the stimulating solutions and placing cells on ice. Lysis
buffer was added, and immunoprecipitation was carried out as above.
Phosphopeptide Mapping-- The resulting pellet was resuspended in 10 µl of electrophoresis buffer containing acetic acid:formic acid:deionized water (15:5:80). Samples were then spotted onto a Silica Gel 60 TLC plate. The peptides were separated by electrophoresis at 1000 V for approximately 60 min at 4 °C in the first dimension using Orange G and Acid Fuchsin as marker dyes. Plates were dried, and peptides were then subjected to ascending chromatography in a solution containing n-butyl alcohol:pyridine:acetic acid:formic acid:deionized water (127.5:22.5:45:15:90) for 6 h. Plates were again dried, and radioactive peptides were identified by autoradiography. Phosphoamino Acid Analysis--
The pellet was resuspended in
200 µl of 6 M HCl and incubated at 110 °C for 2.5 h. The hydrolysate was lyophilized, and the pellet was resuspended in
10 µl of first dimension electrophoresis buffer (pH 1.9) (formic acid
(88% w/v):glacial acetic acid:deionized water (1:3.1:35.9)). Samples
(5-10 µl) were spotted onto cellulose TLC plates using 2 µl each
of phosphothreonine, phosphoserine, and phosphotyrosine (1 mg/ml) as
standards. Green marker dye (5 mg/ml
Protein Phosphorylation in RINm5F Cells-- The initial aim of this study was to investigate changes in threonine and serine phosphorylation in lysates of RINm5F cells that had been stimulated with the nutrient secretagogue glyceraldehyde. Commercial grade serine and threonine antibodies were used to study changes in protein phosphorylation. The serine antibody detected phosphorylated proteins only poorly (Fig. 1A). The threonine antibody proved to be more efficient. Stimulation of RINm5F cells with 10 mM glyceraldehyde resulted in an increase in threonine phosphorylation of a protein that comigrated with the 200-kDa marker (Fig. 1B). Although a 66-kDa protein showed higher basal levels of threonine phosphorylation, it was the 200 kDa protein that predominantly increased in threonine phosphorylation upon stimulation of these cells. Competition experiments demonstrated that the phosphothreonine antibody was specific for phosphothreonine residues because preincubation with 1 mM phosphothreonine completely abolished the immunoreactivity of the 200-kDa protein (Fig. 1C, lane 2). In contrast, clearly detectable signals were still obtained after preincubation with 1 mM phosphoserine or threonine itself (Fig. 1C, lanes 3 and 4).
Time Course of Threonine Phosphorylation-- To extend the relevance of this response to nontumoral cells, pancreatic islets were stimulated with glucose (16.7 mM), and threonine phosphorylation was determined over a series of time intervals (Fig. 2A). In islets there was also an increase in threonine phosphorylation of a 200-kDa protein. This response was rapid in onset, reached a maximum by 5 min, and declined toward basal levels by 15 min. Fig. 2B shows the similar time courses undertaken in RINm5F cells using glyceraldehyde (10 mM) and a depolarizing agent KCl (30 mM), both of which promote Ca2+ influx through voltage-gated ion channels. Stimulation with KCl resulted in a transient increase in threonine phosphorylation very similar to that seen with glucose in islets, except that it approached its peak within 1 min. The glyceraldehyde response showed a slightly different pattern, being slower in onset, peaking at 15 min, and remaining elevated up to 30 min. In RINm5F cells, stimulation with glyceraldehyde and KCl resulted in an increase in [Ca2+]i. In parallel experiments using the Ca2+ indicator Fura 2AM, we found that the peak rise in [Ca2+]i after KCl stimulation (10-15 s) preceded that for glyceraldehyde (1-2 min) (data not shown). The peaks in [Ca2+]i therefore preceded or were coincident with the maximal increases in threonine phosphorylation of the 200-kDa protein seen for each of these stimuli. In all instances KCl gave greater maximal increases in threonine phosphorylation than glyceraldehyde (5-fold versus 3-fold), which corresponds to their relative abilities to raise [Ca2+]i (data not shown).
Ca2+ Dependence of Threonine Phosphorylation-- The relationship between the time courses of phosphorylation and rises in [Ca2+]i suggested that the increase in threonine phosphorylation may be Ca2+-dependent. This was further substantiated in experiments in which intact RINm5F cells were stimulated with KCl and glyceraldehyde in the presence of verapamil (a Ca2+ channel antagonist). This agent caused a significant decrease in stimulated threonine phosphorylation of the 200-kDa protein in response to KCl and glyceraldehyde (Fig. 3A), indicating that an influx of extracellular Ca2+ was important for the initiation of this response. To further confirm the Ca2+ dependence, RINm5F cells were permeabilized with 10 µM digitonin and incubated in a range of Ca2+ buffers reflecting the expected [Ca2+]i range from basal state (0.1 µM) to maximally stimulated (10 µM) (36). As shown in Fig. 3B, a small increase in [Ca2+]i from 0.1 to 0.15 µM was sufficient to increase threonine phosphorylation of the 200-kDa protein. This response was also concentration-dependent with further increases in [Ca2+]i resulting in increases in threonine phosphorylation of the protein. This further supported the hypothesis that the response was tightly linked to the [Ca2+]i.
Protein Kinases Potentially Responsible for Threonine Phosphorylation of the 200-kDa Protein-- We next sought to establish which kinase(s) was involved in the phosphorylation of this 200-kDa substrate. The CaM kinase II family of kinases, some of which are well expressed in insulin-secreting cells (39), can be inhibited with KN-93. However, a potential problem with the use of this compound is that it can also inhibit L-type Ca2+ channels (40). To overcome this, experiments were performed in digitonin-permeabilized cells. However, in three experiments, KN-93 (0.1-10 µM) did not alter the threonine phosphorylation of the 200-kDa protein at either basal (0.1 µM) or stimulated (1.0 µM) Ca2+ (data not shown). The effects of other kinases were next investigated. Intact RINm5F cells were incubated in the presence of TPA (100 nM), which is a phorbol ester and activator of conventional PKCs, and forskolin (30 µM), which activates PKAs. The immunoblot represented in Fig. 4 (A) shows that neither TPA nor forskolin increased threonine phosphorylation of the 200-kDa protein. Fig. 4 (B) represents the mean results from two insulin secretion experiments that were carried out in parallel to the protein phosphorylation. Although forskolin by itself had no effect, it potentiated KCl-induced insulin secretion. Incubation of intact cells with TPA resulted in a marked increase (~2.9-fold/basal) in insulin secretion. These results show that although forskolin and TPA are activating PKAs and PKCs, respectively, to promote secretion, these kinases do not appear to be directly responsible for the threonine phosphorylation of the 200-kDa protein.
Identification of the 200-kDa Protein-- An obvious candidate for the 200-kDa phosphoprotein would be MHC. To test this possibility, MHC from control and KCl-stimulated RINm5F cell lysates was immunoprecipitated using a polyclonal nonmuscle myosin antibody. Fig. 5A represents the immunoblot using the same nonmuscle myosin antibody. The antibody was strongly immunoreactive with a protein comigrating with the 200-kDa marker. The protein that was immunoprecipitated also increased in threonine phosphorylation in KCl-stimulated cells as shown in Fig. 5B.
Phosphopeptide Mapping-- Phosphopeptide mapping was undertaken to determine whether the site of phosphorylation of MHC in RINm5F cells stimulated with glyceraldehyde or KCl was the same. The 32P-labeled myosin was immunoprecipitated from control, glyceraldehyde- and KCl-stimulated cells and subjected to tryptic digestion. Peptides were separated via electrophoresis (E) and ascending chromatography (C). Representative autoradiograms are shown in Fig. 7. There is a basally phosphorylated peptide present (peptide-1) that increases in phosphorylation upon stimulation with both KCl and glyceraldehyde. In addition to this, one major (peptide-2) and two minor peptides (peptides 3 and 4) are also phosphorylated in stimulated cells but to a lesser degree. Importantly, under both conditions the phosphorylated peptides show a similar migratory pattern, suggesting that they are in fact identical and that the target sites of phosphorylation for these two stimulants is the same. However, it cannot be excluded that additional sites are phosphorylated but remain undetected because of limitations in the lower degree of incorporation of 32P into RINm5F cells as opposed to other (e.g. RBL-2H3) cells.2
Phosphoamino Acid Analysis-- Phosphoamino acid analysis was undertaken to confirm the increase in threonine phosphorylation of MHC upon stimulation of RINm5F cells. The 32P-labeled myosin was immunoprecipitated from control and KCl-stimulated RINm5F cells and subjected to tryptic digestion, amino acid hydrolysis, and two-dimensional phosphoamino acid analysis. Fig. 8 (left panel) is a representative result. From analysis of the phosphorimage we were able to measure semiquantitatively the changes in phosphothreonine and phosphoserine (Fig. 8, right panel). MHC displayed a high degree of serine phosphorylation under basal conditions, and this increased 2.2-fold upon stimulation with KCl. In contrast threonine phosphorylation was very low in unstimulated cells but increased markedly in response to KCl (~5.4-fold/basal). This densitometric analysis was confirmed by removal of the spots from the plate and quantification of the radioactivity present by Cerenkov counting (data not shown). These results, therefore, confirmed that MHC does undergo an increase in threonine phosphorylation and, in addition to the competition data (Fig. 1), validates that the anti-phosphothreonine antibody used above was specific for phosphothreonine residues. They also reveal an increase in serine phosphorylation that was undetectable with the anti-phosphoserine antibody (data not shown).
Subtypes of Myosin in RINm5F Cells and Islets-- The polyclonal nonmuscle myosin antibody potentially immunoreacts with a number of different subtypes of myosin. Using antibodies generated against synthetic peptides of specific regions of myosin IIA and myosin IIB, we were able to establish the subtypes present in RINm5F and islet cells. Fig. 9 (A and B) represents an immunoblot obtained using these antibodies with four different cell types. We have confirmed that RBL-2H3 mast cells, as previously reported, contained only myosin IIA (41). COS-7 cells contained only myosin IIB. There was no cross-reactivity of the antibodies, demonstrating that they were specific for their respective myosin isoform. Importantly, RINm5F cells and islets were shown here to contain both the myosin IIA and myosin IIB isoforms.
Identity of Threonine-phosphorylated Myosin Isoform-- To examine the threonine phosphorylation of the individual MHC isoforms, proteins were immunoprecipitated from control and KCl-stimulated RINm5F cells using the anti-phosphothreonine antibody. A sample of the immunoprecipitate was subjected to 10% SDS-PAGE and stained with Coomassie Blue. The protein loading was corrected according to the amount of total MHC present as assessed densitometrically. Immunoblots using the specific myosin IIA and myosin IIB antibodies are represented in Fig. 9 (C and D), respectively. These show that more myosin IIA, as compared with myosin IIB, is recruited to the immunoprecipitates following stimulation. Densitometric analysis of this and replicate experiments revealed a stimulated increase of 4.5 ± 1.0-fold over basal for myosin IIA as opposed to 2.3 ± 0.5-fold for myosin IIB. These results suggest that myosin IIA is the predominant threonine-phosphorylated species following stimulation.
The initial steps of nutrient metabolism in the pancreatic
Irrespective of the potential role of threonine phosphorylation in Ca2+-dependent insulin secretion, it is apparent that these two processes do not correspond in a moment to moment basis, because threonine phosphorylation is transient in islets in response to glucose, whereas secretion would be expected to be ongoing. The short-lived nature of this response does not preclude MHC phosphorylation from having a possible important role in initiating secretion. This transient response was also seen in KCl-stimulated RINm5F cells, suggesting that a prolonged elevation of [Ca2+]i might also regulate the dephosphorylation of the 200-kDa protein, possibly by activation of the Ca2+-dependent phosphatases (44, 45). The anti-phosphothreonine antibody used in these studies detects net changes in phosphorylation, suggesting that the transient response to glucose is indeed real. This might not necessarily be the case in metabolic labeling experiments, in which an apparent decrease in phosphorylation might be because of a decrease in the specific activity of the intracellular ATP pool, secondary to nutrient metabolism. There is strong evidence for the role of CaM kinases as primary
regulators of the insulin secretory response (13, 46, 47). A subtype of
this family, CaM kinase II, has been reported to phosphorylate a number
of cytoskeleton-associated proteins including synapsin I, an important
protein involved in neurotransmitter release (48, 44) and MAP2, a
microtubule protein (16). An isoform of CaM kinase II,
Myosin can be classified as conventional (Type II) and unconventional
(all other types) on the basis of the structure of its head region.
Myosin is ubiquitously expressed, and a particular cell type expresses
a variety of myosin subtypes (18). Moreover, it is becoming clear that
the role of each subtype may be different, making it important to
identify the myosins that may be involved in secretion. Recent work
with the unconventional myosins, in particular Type V, has demonstrated
that they have a function in vesicular movement (50, 51). However,
there is also limited but growing evidence that the Type II myosin
might play an important role in the regulation of secretion. Myosin
Type II has been implicated in the regulation of neurotransmitter
release because microinjection of an inhibitory myosin II antibody was
found to retard synaptic transmission (22). Myosin II and the
phosphorylation of its heavy and light chains is also thought to be
important in the regulation of histamine release in rat mast cells
(RBL-2H3) (21). More recently it has been shown in a mouse In nonmuscle cells myosin II exists as two isoforms, IIA and IIB, which are expressed in different ratios in a tissue-dependent manner (27). We have shown for the first time that RINm5F and rat islets contain both myosin IIA and IIB subtypes. It is now becoming apparent that these subtypes also display different subcellular distributions (55, 56), and it is possible that one of the factors that determines their localization is differential phosphorylation. Myosin IIB has an insert that varies in size depending on the species in which it is expressed. This insert in oocytes is known to be phosphorylated by Cdc2 kinase during meiosis, which is thought to regulate the location of this myosin subtype (57). Interestingly, in RINm5F cells it appears that myosin IIA is the subtype predominantly threonine-phosphorylated upon stimulation. This then raises the possibility that the two myosin subtypes are differentiallly regulated and might exert different functions. An alternative possibility, which remains to be tested, is that myosin IIB is serine-phosphorylated by Ca2+-dependent kinases, and this exerts the same functional consequences as phosphorylation of an equivalent threonine residue in myosin IIA. One final question to address is how MHC phosphorylation might regulate insulin secretion. Although the role of regulatory light chains in controlling myosin function, at least at the level of ATPase activity, is well documented (23), it is now becoming apparent that regulation of this complex could also occur via phosphorylation of the heavy chain (21, 30, 31, 58-60). An important structural characteristic of MHC is that it consists of a globular, amino-terminal head domain, which contains the actin- and ATP-binding sites, and a carboxyl terminus that, when dimerized, forms a coiled-coil rod structure (58). From studies in the protozoans Dictyostelium and Acanthamoeba, it has been found that phosphorylation, in particular the location of this phosphorylation, on MHC has a number of consequences. In Acanthamoeba, MHC phosphorylation inhibits both the ATPase activity and filament formation in vitro (59). In Dictyostelium, phosphorylation of three threonine residues in the tail region of MHC alters only filament formation (31, 60). It has also been recently demonstrated that phosphorylation of the tail region of MHC in rabbit brain also disrupts filament formation (61). The conclusion emerging from these studies is that phosphorylation of MHC in the head region appears to affect actin binding and ATPase activity, thereby modifying its contractile activity, whereas phosphorylation on the tail region of MHC is thought to alter filament formation (30). Based on the protozoan models, it had been hypothesized that phosphorylation of vertebrate MHC in the tail region might result in filament instability and the breakdown of the cortical actin web, which then allows easier access of the granules to the plasma membrane (21). In addition to the evidence already presented, it has recently been demonstrated in Dictyostelium that the threonine phosphorylation on the tail of the MHC also plays a role in localizing the protein during cytokinesis (60), confirming that phosphorylation of MHC may be important in determining the locality of the protein within the cell. The phosphorylation of MHC is therefore potentially involved in regulation of the myosin complex, and hence secretion, via a number of mechanisms. Which, if any, of these mechanisms is actually involved remains to be determined.
We thank Dr. Robert Adelstein for the generous gift of the myosin IIA and IIB antibodies and Douglas Campbell for assistance with the phosphoamino acid analysis. We also thank Dr. Carsten Schmitz-Peiffer, Dr. Boris Sarcevic, and Dr. Jon Izant for critical reading of the manuscript.
* This work was supported by a National Health and Medical Research Council block grant.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Recipient of an Australian Postgraduate Award.
** To whom correspondence should be addressed: Garvan Inst. of Medical Research, 384 Victoria St., Darlinghurst, NSW 2010, Australia. Tel.: 61-2-9295-8204; Fax: 61-2-9295-8201; E-mail: t.biden{at}garvan.unsw.edu.au.
The abbreviations used are:
PKC, protein kinase
C; CaM, Ca2+/calmodulin-dependentPKA, protein
kinase AMHC, myosin heavy chainMLC, myosin light chainKRB, Krebs-Ringer bufferTPA, 12-O-tetradecanoyl
phorbol- 2 J. R. Wilson, R. I. Ludowyke, and T. J. Biden, unpublished observations.
Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc. This article has been cited by other articles:
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Advertisement | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||